Literature DB >> 25085808

The Japanese Breast Cancer Society Clinical Practice Guideline for screening and imaging diagnosis of breast cancer.

Mitsuhiro Tozaki1, Ichiro Isomoto, Yasuyuki Kojima, Kazunori Kubota, Yoshifumi Kuroki, Koji Ohnuki, Shozo Ohsumi, Hirofumi Mukai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25085808     DOI： 10.1007/s12282-014-0557-8

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  4 in total

1.  Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast.

Authors:  Kunsei Lee; Hyeongsu Kim; Jung Hyun Lee; Hyoseon Jeong; Soon Ae Shin; Taehwa Han; Young Lan Seo; Youngbum Yoo; Sang Eun Nam; Jong Heon Park; Yoo Mi Park
Journal:  BMC Womens Health       Date:  2016-11-18       Impact factor: 2.809

2.  Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.

Authors:  Xiuyan Yu; Guoming Hu; Zhigang Zhang; Fuming Qiu; Xuan Shao; Xiaochen Wang; Hongwei Zhan; Yiding Chen; Yongchuan Deng; Jian Huang
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

3.  The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.

Authors:  Makiko Kawai; Masako Kataoka; Shotaro Kanao; Mami Iima; Natsuko Onishi; Akane Ohashi; Rena Sakaguchi; Masakazu Toi; Kaori Togashi
Journal:  Magn Reson Med Sci       Date:  2017-12-07       Impact factor: 2.471

4.  Editorial: HBOC and high-risk screening: up-to-date.

Authors:  Masako Kataoka
Journal:  Breast Cancer       Date:  2021-08-23       Impact factor: 4.239
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.